# Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

> **NCT00364780** · PHASE2 · COMPLETED · sponsor: **Kadmon Corporation, LLC** · enrollment: 55 (actual)

## Conditions studied

- Non-small-cell Lung Cancer

## Interventions

- **DRUG:** XL647

## Key facts

- **NCT ID:** NCT00364780
- **Lead sponsor:** Kadmon Corporation, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-08
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364780, "Study of XL647 in Subjects With Non-Small-Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00364780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*